CAAS
IART icon

Capital Asset Advisory Services’s Integra LifeSciences IART Stock Holding History

Capital Asset Advisory Services’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-74
Closed -$5K – 1045
2020
Q4 		$5K Buy
+74
New +$3.98K ﹤0.01% 1276

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Asset Advisory Services's IART Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 74 shares — an estimated $5K sold.

Capital Asset Advisory Services first reported a position in IART in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 74 Integra LifeSciences shares in Q1 2021, an estimated $5K.
  • Capital Asset Advisory Services first reported a position in Integra LifeSciences in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's Integra LifeSciences position peaked at $5K in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.